1. Is there anything new for relapsed AML? Steven M. Kornblau, M.D. Department of Leukemia Department of Stem Cell Transplantation and Cellular Therapy 2. The Status Quo…
Slide 1 1. Department of Ophtalmology, Semmelweis University 2. 2nd Department of Pathology, Semmelweis University 3. Department of Ophthalmology, United St. István and…
Pamidronate Smoldering or âAsymptomaticâ MM Approximately 15% of cases of MM Risk of progression to âsymptomaticâ MM Mayo Clinic 10%/y during the first 5 y 3%/y during…
Inmunomoduladores en Mieloma Múltiple: Pasado, Presente y Futuro Relapsed and Refractory Myeloma Ruben Niesvizky Myeloma Center Myelomacenter.org [email protected]…
Epidemiology: âThe times, they are a changing..â Kieren A. Marr MD Director, Transplant and Oncology ID Johns Hopkins University School of Medicine Historic Observations:…
Iron Chelator Basics: Emerging Data Beyond Transfusion-Dependent Iron Overload Antonello Pietrangelo, MD, PhD Professor of Internal Medicine Center for Hemochromatosis University…
1. Carlos Eduardo Vallejo Bocanumen Residente Medicina de Urgencias U de A 2. 1933.Cooke–hemorragia submucosa yapendicitis perforada. 1969. Amromin– 69 casos de EN. Leuc.…